Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVMI
4376
Nova
NVMI
$12.4B
| $51.9K | ﹤0.01% |
635
-916
| -59% | -$74.7K |
|
4377
Prime Medicine
PRME
$527M
| $51.8K | ﹤0.01% |
+2,787
| New | +$50.3K |
|
4378
Oil-Dri
ODC
$1.44B
| $51.7K | ﹤0.01% |
3,082
| – | – |
|
|
CGAU
4379
Centerra Gold
CGAU
$3.36B
| $51.3K | ﹤0.01% |
9,900
+500
| +5% | +$2.48K |
|
4380
Waldencast
WALD
$222M
| $50.8K | ﹤0.01% |
5,593
-200
| -3% | -$1.86K |
|
|
GBIO
4381
DELISTED
Generation Bio
GBIO
| $50.7K | ﹤0.01% |
1,291
+1,087
| +533% | +$57.1K |
|
4382
Rimini Street
RMNI
$449M
| $50.5K | ﹤0.01% |
13,252
+11,189
| +542% | +$49.7K |
|
4383
Invesco NASDAQ 100 ETF
QQQM
$96.7B
| $50.4K | ﹤0.01% |
+460
| New | +$52.3K |
|
|
SRT
4384
DELISTED
Startek Inc.
SRT
| $50.3K | ﹤0.01% |
13,419
-1,744
| -12% | -$6.15K |
|
4385
Vivid Seats
SEAT
$84.6M
| $50.3K | ﹤0.01% |
344
+28
| +9% | +$4.35K |
|
4386
Blue Bird Corp
BLBD
$2.35B
| $50.3K | ﹤0.01% |
4,692
+3,590
| +326% | +$36.1K |
|
4387
Global X Uranium ETF
URA
$5.42B
| $50.2K | ﹤0.01% |
2,500
-49,656
| -95% | -$1M |
|
4388
PUT
Legend Biotech
LEGN
$3.59B
| $49.9K | ﹤0.01% |
+1,000
| New | +$48.4K |
|
|
WHWK
4389
Whitehawk Therapeutics
WHWK
$190M
| $49.9K | ﹤0.01% |
3,888
+3,274
| +533% | +$42.7K |
|
4390
ProShares Short QQQ
PSQ
$824M
| $49.8K | ﹤0.01% |
676
| – | – |
|
4391
Distribution Solutions Group
DSGR
$1.6B
| $49.5K | ﹤0.01% |
2,686
+2,268
| +543% | +$38.1K |
|
4392
FingerMotion
FNGR
$16.6M
| $49.2K | ﹤0.01% |
+17,524
| New | +$95.5K |
|
|
TUP
4393
DELISTED
Tupperware Brands Corporation
TUP
| $49.1K | ﹤0.01% |
11,848
-3,707
| -24% | -$19.9K |
|
4394
Motley Fool 100 Index ETF
TMFC
$2.05B
| $48.9K | ﹤0.01% |
1,606
| – | – |
|
|
VSTO
4395
CALL
DELISTED
Vista Outdoor Inc.
VSTO
| $48.7K | ﹤0.01% |
+2,000
| New | +$52.6K |
|
4396
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
| $48.7K | ﹤0.01% |
360
| – | – |
|
4397
Equinox Gold
EQX
$7.06B
| $48.6K | ﹤0.01% |
14,831
-19,900
| -57% | -$68.6K |
|
4398
AXT Inc
AXTI
$3.95B
| $48.4K | ﹤0.01% |
11,049
+9,329
| +542% | +$45.5K |
|
4399
Aveanna Healthcare
AVAH
$2.04B
| $48.3K | ﹤0.01% |
61,984
-1,030
| -2% | -$1.08K |
|
|
MTL.PR
4400
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
| $48.2K | ﹤0.01% |
40,000
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 798 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 798 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.